PRESS RELEASES

Year
November 23 | 2020
RAPT Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 16 | 2020
RAPT Therapeutics Reports Third Quarter 2020 Financial Results
November 16 | 2020
RAPT Therapeutics Reports Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
November 15 | 2020
RAPT Therapeutics to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
November 13 | 2020
RAPT Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
October 14 | 2020
RAPT Therapeutics Appoints Lisa Butterfield, Ph.D., and Lawrence Fong, M.D., to Scientific Advisory Board
September 03 | 2020
RAPT Therapeutics to Present at Upcoming Virtual Investor Conferences
August 13 | 2020
RAPT Therapeutics Reports Second Quarter 2020 Financial Results
August 05 | 2020
RAPT Therapeutics Appoints Phyllis Loud Gray as Vice President of Human Resources
June 18 | 2020
Peter Svennilson Elected to RAPT Therapeutics Board of Directors